Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)

NCT01256775 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: NCX-4016
DRUG: NCX4016 placebo

Sponsor

NicOx Research Institute S.r.l.